Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FATE
Recent news which mentions FATE
< Previous
1
2
3
4
5
Next >
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
June 03, 2022
Tickers
ADPT
AGLE
ALLO
AON
Tags
MARA
MCO
Intraday Update
From
Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
May 20, 2022
Tickers
BMY
FATE
IBB
JNJ
Tags
UCBJY
LIAN
PFE
From
MarketWatch
Recap: Fate Therapeutics Q1 Earnings
May 04, 2022
Tickers
FATE
Tags
BZI/Recaps
Market News
Benzinga
From
Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Tickers
AGTC
ALLO
ALNA
AMRN
Tags
RGNX
Biotech
FATE
From
Benzinga
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
May 02, 2022
Tickers
APPN
ARKK
BILI
BLDP
Tags
CHWY
FATE
RDFN
From
MarketWatch
What 4 Analyst Ratings Have To Say About Fate Therapeutics
March 04, 2022
Tickers
FATE
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Fate Therapeutics: Q4 Earnings Insights
February 28, 2022
Tickers
FATE
Tags
FATE
Earnings
Benzinga
From
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers
AAON
ACAD
ACHC
AGM
Tags
NVAX
JLL
DDD
From
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers
ACAD
ACLX
AMRN
AMRS
Tags
ACAD
HZNP
RETA
From
Benzinga
Fate Therapeutics's Earnings: A Preview
February 25, 2022
Tickers
FATE
Tags
FATE
BZI/EP
Earnings
From
Benzinga
Earnings Outlook For Fate Therapeutics
February 25, 2022
Tickers
FATE
Tags
Market News
Benzinga
FATE
From
Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Tickers
BMY
FATE
IPSC
Tags
IPSC
Analyst Color
General
From
Benzinga
Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?
January 14, 2022
Tickers
ARKF
ARKG
ARKK
ARKW
Tags
ETFs
SQ
Long Ideas
From
Benzinga
Here's How Much $100 Invested In Fate Therapeutics 5 Years Ago Would Be Worth Today
January 05, 2022
Tickers
FATE
Tags
BZI/POD
FATE
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Tickers
ADGI
ALB
AMCR
APEN
Tags
UWMC
FREE
LTHM
From
Benzinga
10 Biggest Price Target Changes For Wednesday
December 15, 2021
Tickers
ADGI
BKNG
EW
FATE
Tags
ADGI
Small Cap
SIX
From
Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Tickers
APTO
ATRA
AZN
BLU
Tags
FDA
Benzinga
RHHBY
From
Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
December 14, 2021
Tickers
FATE
Tags
General
Movers
FATE
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
Tickers
APD
APPS
ARVN
AZN
Tags
CMCO
SMG
TACO
From
Benzinga
Cathie Wood Likes Fate Therapeutics, Should You?
December 01, 2021
Tickers
FATE
TWST
Tags
Market News
Recent Press Releases
FATE
From
Motley Fool
3 Biotech Stocks That Can Double Your Money, According to Wall Street
November 25, 2021
Tickers
ADPT
AXSM
FATE
Tags
Market News
Recent Press Releases
AXSM
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
November 09, 2021
Tickers
ADCT
ADMA
AQB
BPOP
Tags
Market News
Analyst Ratings
SGEN
From
Benzinga
Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
FATE
Tags
Market News
Recent Press Releases
FATE
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
IOVA
ILMN
FULC
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
SGMO
Top Stories
DMAC
From
Benzinga
3 Biotech Stocks to Watch Now
October 12, 2021
Tickers
ACAD
FATE
PIRS
Tags
ACAD
Small Cap
Market News
From
Benzinga
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
September 14, 2021
Tickers
ARKG
ARKK
FATE
Tags
Market News
ARKK
FATE
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
Tickers
AFCG
ALLK
APPH
AY
Tags
ICMB
PNR
CPNG
From
Benzinga
58 Biggest Movers From Friday
August 23, 2021
Tickers
AMRS
ARAY
ARCE
ATER
Tags
INTA
SONN
FLGC
From
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 20, 2021
Tickers
ALLO
AXDX
ENDP
ENSC
Tags
ENSC
Intraday Update
Market News
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.